Solarea Bio

Drug Discovery · Waltham, MA · Founded 2017 · Privately Held (backing)

Developer of microbiome-based health products designed to address age-related inflammatory conditions and improve overall health. Solarea Bio is based in Waltham, MA and was founded in 2017. It was valued at $37 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $37.4 million across 4 recorded rounds; the latest was a $9.9 million early-stage round in Nov 2025.

PMV mark · valuation
$37.0M
Oct 2026
Priced at
its later-stage round
Nov 2025
Total raised
$37.4M
Last round
Early Stage VC
Nov 2025
Cap table — not yet on record

Solarea Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Solarea Bio with a free account
  • ·The complete investor list: 12 names
  • ·Watch Solarea Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Solarea Bio

Where does Solarea Bio's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Solarea Bio's 4 recorded funding rounds.